Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alma Osmanovic

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Brain Sciences|April 3, 2021
Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy PatientsAlma Osmanovic, Olivia Schreiber-Katz, Susanne Petri
BMC Medical Genetics|March 4, 2020
Identification of a rare SEPT9 variant in a family with autosomal dominant Charcot-Marie-Tooth diseaseGerrit M Grosse, Christine Bauer, Bruno Kopp, et al.
Journal of Neurology|April 16, 2023
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapyBogdan Bjelica, Camilla Wohnrade, Alma Osmanovic, et al.
Orphanet Journal of Rare Diseases|June 14, 2020
Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in GermanyErik Schönfelder, Alma Osmanovic, Lars Hendrik Müschen, et al.
Journal of Neuromuscular Diseases|December 16, 2025
Sleep quality, restless legs syndrome and daytime sleepiness in adults with 5q-spinal muscular atrophyBogdan Bjelica, Kaan Bacara, Camilla Wohnrade, et al.
BMC Neurology|February 17, 2024
Risdiplam therapy in adults with 5q-SMA: observational study on motor function and treatment satisfactionBogdan Bjelica, Camilla Wohnrade, Iraima Cespedes, et al.
Muscle & Nerve|June 14, 2024
Metabolic syndrome is common in adults with 5q-spinal muscular atrophy and impacts quality of life and fatigueBogdan Bjelica, Camilla Wohnrade, Alma Osmanovic, et al.
Scientific Reports|April 17, 2023
Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophyOlivia Schreiber-Katz, Hannah Alexandra Siegler, Gary Wieselmann, et al.
Journal of Neurology|October 8, 2020
An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatmentCamilla Binz, Olivia Schreiber-Katz, Mareike Kumpe, et al.
Journal of Neurology|October 14, 2025
Beyond motor neurons: autonomic dysfunction and ECG findings in adults with 5q-spinal muscular atrophyKaan Bacara, Stevan D Stojanovic, Camilla Wohnrade, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Brain Sciences|April 3, 2021
Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy PatientsAlma Osmanovic, Olivia Schreiber-Katz, Susanne Petri
BMC Medical Genetics|March 4, 2020
Identification of a rare SEPT9 variant in a family with autosomal dominant Charcot-Marie-Tooth diseaseGerrit M Grosse, Christine Bauer, Bruno Kopp, et al.
Journal of Neurology|April 16, 2023
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapyBogdan Bjelica, Camilla Wohnrade, Alma Osmanovic, et al.
Orphanet Journal of Rare Diseases|June 14, 2020
Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in GermanyErik Schönfelder, Alma Osmanovic, Lars Hendrik Müschen, et al.
Journal of Neuromuscular Diseases|December 16, 2025
Sleep quality, restless legs syndrome and daytime sleepiness in adults with 5q-spinal muscular atrophyBogdan Bjelica, Kaan Bacara, Camilla Wohnrade, et al.
BMC Neurology|February 17, 2024
Risdiplam therapy in adults with 5q-SMA: observational study on motor function and treatment satisfactionBogdan Bjelica, Camilla Wohnrade, Iraima Cespedes, et al.
Muscle & Nerve|June 14, 2024
Metabolic syndrome is common in adults with 5q-spinal muscular atrophy and impacts quality of life and fatigueBogdan Bjelica, Camilla Wohnrade, Alma Osmanovic, et al.
Scientific Reports|April 17, 2023
Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophyOlivia Schreiber-Katz, Hannah Alexandra Siegler, Gary Wieselmann, et al.
Journal of Neurology|October 8, 2020
An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatmentCamilla Binz, Olivia Schreiber-Katz, Mareike Kumpe, et al.
Journal of Neurology|October 14, 2025
Beyond motor neurons: autonomic dysfunction and ECG findings in adults with 5q-spinal muscular atrophyKaan Bacara, Stevan D Stojanovic, Camilla Wohnrade, et al.
Pageof 5